| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Medical and professional news |
| Population | Men |
| Source | News-Medical |
| URL | news-medical.net/news/20260902/Too-little-or-too-much-testosterone-may-matter-for-heart-rhythm.aspx (opens in a new tab) |
Specific claim evaluated
Atrial fibrillation risk may be higher at both low and high testosterone concentrations, while evidence that testosterone therapy itself consistently increases atrial fibrillation risk remains mixed.
Primary research supporting or contradicting the claim
A structured narrative review of randomized trials, cohorts and Mendelian randomization studies described a U-shaped relationship between testosterone and atrial fibrillation, with more consistent evidence at the high end (Maligireddy et al., 2026). In TRAVERSE, atrial fibrillation was more frequent with testosterone than with placebo (Lincoff et al., 2023).
Corrected evidence-based interpretation
The report is correct. The suggested range of about 350 to 550 ng/dL has not been validated prospectively as a target for preventing atrial fibrillation.
Rationale for grade
The article identifies the source as a narrative review, states that the proposed optimal range is unvalidated and avoids causal language. Its account of the trial and meta-analytic evidence is consistent with the primary sources.
References
- Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. PMID
Supporting excerpt: "noninferior to placebo with respect to the incidence of major adverse cardiac events" - Maligireddy AR, Barua ST, Barua RS. Association of testosterone and testosterone replacement therapy with atrial fibrillation: an updated review. J Endocr Soc. 2026;10(9):bvag180. PMID
Supporting excerpt: "Converging evidence thus supports a U-shaped T-AF relationship."